Twist Bioscience Corp — Director's Dealing 2019

Oct 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-10-25

Reporting Person: Finn Patrick John (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-25	Common Stock	M	26398	$1.19	Acquired	32400	Direct
2019-10-25	Common Stock	M	4753	$5.95	Acquired	37153	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-25	Employee Stock Option (right to buy)	$1.19	M	26398	Disposed	2025-02-03	Common Stock (26398)	Direct
2019-10-25	Employee Stock Option (right to buy)	$5.95	M	4753	Disposed	2025-09-28	Common Stock (4753)	Direct

Footnotes

F1: The option is immediately exercisable. 25% of the shares subject to the option vested on February 2, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F2: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.